Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for interventions to reduce bruising after cellulite treatment with CCH-aaes (QWO) in the buttocks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QWO (collagenase clostridium histolyticum-aaes)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Status: COMPLETED | Results posted: 2025-03-07